Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
Early-Career Opportunities
IASLC Academy
Publications, Resources & Guidelines
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 1801 - 1812 items out of 1999 results
ILCN article
Should Biomarkers Be Used in the Clinical Management of ES-SCLC?
ILCN article
US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR
ILCN article
In Case You Missed It: IASLC Launches New Education Center
Meeting
2024 Masters in Thoracic Oncology Summit
Podcast
FDA Approval: FLAURA2, First Line Osimertinib Plus Chemotherapy for EGFR NSCLC
ILCN article
IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion
Podcast
IASLC DEI Initiative Global Member Survey
ILCN article
FLAURA 2 Post-progression Outcomes Demonstrate Consistent Benefit, Favor Combination Arm
ILCN article
Antibody Drug Conjugates: Diamonds in the Rough?
ILCN article
The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology
ILCN article
US Food and Drug Administration Accepts New Drug Application for Ensartinib
Podcast
FDA Approval: Adjuvant Alectinib for Resected NSCLC
Pagination
First
First page
‹
Previous page
…
147
148
149
150
151
152
153
154
155
…
›
Next page
Last
Last page